Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease

Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease

BACKGROUND: Patients with Type 2 Diabetes (T2DM) and patients on maintenance hemodialysis (MHD) are at a high risk of adverse clinical course of COVID-19. To date, the causes of high mortality in these groups are not fully understood. Data about peculiarity of clinical course and Tocilizumab (TCZ) a...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Zeltyn-Abramov, M. A. Lysenko, N. F. Frolova, T. N. Markova, N. I. Belavina, N. N. Klochkova, S. V. Kondrashkina, R. T. Iskhakov, A. I. Ushakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2021-02-01
Series:Сахарный диабет
Subjects:
covid-19
risk factors
diabetes mellitus
diabetic kidney disease
maintenance hemodialysis
tocilizumab
Online Access:https://www.dia-endojournals.ru/jour/article/view/12688
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dia-endojournals.ru/jour/article/view/12688

Similar Items